5 Pharmaceutical Stocks to Buy According to Efrem Kamen’s Pura Vida Investments

4. LivaNova PLC (NASDAQ:LIVN)

Number of Hedge Fund Holders: 32

Shares of LivaNova PLC (NASDAQ:LIVN) surged more than 40% in the last twelve months, thanks to strong financial growth. The company’s third-quarter revenue and earnings exceeded forecasts while updated earnings guidance beat the consensus. The company expects earnings per share in the range of $2.00 – $2.10.

In the third quarter investor letter, Diamond Hill Capital, an investment management firm, mentioned LivaNova. Here is what Diamond Hill Capital stated

“Our health care holdings were negative in aggregate, but outpaced index peers, which boosted relative performance along with our below-benchmark positioning On an individual holdings’ basis, we exited global medical technology company LivaNova as shares approached our estimate of intrinsic value.”